Cardiovascular Disease Risk in Children With Type 1 Diabetes Mellitus - Trial NCT06356051
Access comprehensive clinical trial information for NCT06356051 through Pure Global AI's free database. This phase not specified trial is sponsored by Ankara City Hospital Bilkent and is currently Completed. The study focuses on Type 1 Diabetes. Target enrollment is 202 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Ankara City Hospital Bilkent
Timeline & Enrollment
N/A
Jan 01, 2023
Sep 01, 2023
Primary Outcome
Epicardial fat thickness
Summary
Epicardial fat thickness, carotid intima-media thickness, and augmentation index from
 arterial stiffness indicators are increased in children with T1DM compared to the healthy
 control group. These results support the idea that children with T1DM present significant
 changes in important subclinical indicators for the development of cardiovascular disease.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06356051
Device Trial